Quillivant Suspension, Extended Release
Product Images NDC 24478-321

Product Visual Gallery

This gallery contains 23 technical images submitted to the FDA as part of the official labeling for Quillivant (NDC 24478-321). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nextwave Pharmaceuticals, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Quillivant Xr 1

FDA Label Image

Figure M (Quillivant Xr 10)

FDA Label Image

Figure N (Quillivant Xr 11)

FDA Label Image

Prinicpal Display Panelndc 24478-321-02quillivant Xr® Methylphenidate Hci For Extended-release Oral Suspension300 mg/ 60 mL Total Volume(when Reconstituted With 53 mL Of Water)25 mg/5 mL(5 mg/ml) When Reconstitutedrx Only (Quillivant Xr 12)

FDA Label Image

Prinicpal Display Panelndc 24478-322-04quillivant Xr® Methylphenidate Hci For Extended-release Oral Suspension600 mg/ 120 mL Total Volume(when Reconstituted With 105 mL Of Water)25 mg/5 mL(5 mg/ml) When Reconstitutedrx Only (Quillivant Xr 13)

FDA Label Image

Prinicpal Display Panelndc 24478-323-05quillivant Xr® Methylphenidate Hci For Extended-release Oral Suspension750 mg/ 150 mL Total Volume(when Reconstituted With 131 mL Of Water)25 mg/5 mL(5 mg/ml) When Reconstitutedrx Only (Quillivant Xr 14)

FDA Label Image

Prinicpal Display Panelndc 24478-324-06quillivant Xr® Methylphenidate Hci For Extended-release Oral Suspension900 mg/ 180 mL Total Volume(when Reconstituted With 158 mL Of Water)25 mg/5 mL(5 mg/ml) When Reconstitutedrx Only (Quillivant Xr 15)

FDA Label Image

Quillivant Xr 16

FDA Label Image

Quillivant Xr 17

FDA Label Image

Quillivant Xr 18

FDA Label Image

Quillivant Xr 19

NextWave Pharmaceuticals, Inc. is a pharmaceutical company.*

FDA Label Image

Quillivant Xr 2

This text provides a table with the mean d-Methylphenidate plasma concentration (in ng/mL) over a period of time (up to 35 hours) for Quillivant 60mg and Methylphenidate IR Oral Solution at a dosage of 2x30 mg every 6 hours.*

FDA Label Image

Quillivant Xr 20

This text is a product description for Quillivant XR, which is a methylphenidate hydrochloride medication for attention deficit hyperactivity disorder (ADHD). It comes in an oral suspension form. The medication must be reconstituted with 53 mL of water before dispensing, and the pharmacist should provide the enclosed medication guide to each patient. The medication should be shaken well for at least 10 seconds before each use. The total volume of the medication is 300 mg/60 mL. When reconstituted it has a concentration of 25 mg/5 mL (5 mg/mL). It contains both English and non-English characters.*

FDA Label Image

Quillivant Xr 21

Quillivant XR is an extended-release oral suspension of methylphenidate HCI. It is available as a 25mg/5mL solution and must be reconstituted with 105mL of water prior to dispensing. The solution should be shaken well for at least 10 seconds before each use. It is important to keep the medication out of reach of children.*

FDA Label Image

Quillivant Xr 22

FDA Label Image

Quillivant Xr 23

FDA Label Image

Quillivant Xr 3

This appears to be a graph or chart comparing the Mean Combined SKAMP Score + SE of a medication called Quillivant versus a placebo over a period of time measured in hours. However, without more context or information, it is difficult to provide a more detailed or accurate description.*

FDA Label Image

Quillivant Xr 4

NextWave Pharmaceuticals, Inc. is a pharmaceutical company.*

FDA Label Image

Quillivant Xr 5

NextWave Pharmaceuticals, Inc is a pharmaceutical company.*

FDA Label Image

Quillivant Xr 6

FDA Label Image

Quillivant Xr 7

FDA Label Image

Quillivant Xr 8

FDA Label Image

Quillivant Xr 9

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.